[HTML][HTML] Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial

T Sonnweber, S Sahanic, A Pizzini… - European …, 2021 - Eur Respiratory Soc
Background After the 2002/2003 severe acute respiratory syndrome outbreak, 30% of
survivors exhibited persisting structural pulmonary abnormalities. The long-term pulmonary …

Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths

…, M Vidigal, M Zatz, D Van De Beek, S Sahanic… - Science …, 2021 - science.org
Circulating autoantibodies (auto-Abs) neutralizing high concentrations (10 ng/ml; in plasma
diluted 1:10) of IFN-α and/or IFN-ω are found in about 10% of patients with critical COVID-19 …

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

…, M Zatz, D van de Beek, S Sahanic… - Proceedings of the …, 2022 - National Acad Sciences
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection fatality rate (IFR)
doubles with every 5 y of age from childhood onward. Circulating autoantibodies neutralizing …

[PDF][PDF] A time-resolved proteomic and prognostic map of COVID-19

…, SJ Klein, A Pizzini, Y Wohlfarter, S Sahanic… - Cell systems, 2021 - cell.com
COVID-19 is highly variable in its clinical presentation, ranging from asymptomatic infection
to severe organ damage and death. We characterized the time-dependent progression of …

[HTML][HTML] Persisting alterations of iron homeostasis in COVID-19 are associated with non-resolving lung pathologies and poor patients' performance: a prospective …

T Sonnweber, A Boehm, S Sahanic, A Pizzini… - Respiratory …, 2020 - Springer
Background Severe coronavirus disease 2019 (COVID-19) is frequently associated with
hyperinflammation and hyperferritinemia. The latter is related to increased mortality in COVID-19…

Neurological outcome and quality of life 3 months after COVID‐19: A prospective observational cohort study

…, B Heim, V Limmert, S Sahanic… - European journal of …, 2021 - Wiley Online Library
Background and purpose To assess neurological manifestations and health‐related quality
of life (QoL) 3 months after COVID‐19. Methods In this prospective, multicenter, …

Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs

…, M Salagianni, G Poulakou, E Siouti, S Sahanic… - Science …, 2023 - science.org
Life-threatening “breakthrough” cases of critical COVID-19 are attributed to poor or waning
antibody (Ab) response to SARS-CoV-2 vaccines in individuals already at risk. Preexisting …

Phenotyping of acute and persistent Coronavirus disease 2019 features in the outpatient setting: exploratory analysis of an international cross-sectional Online survey

S Sahanic, P Tymoszuk, D Ausserhofer… - Clinical Infectious …, 2022 - academic.oup.com
Background Long COVID, defined as the presence of coronavirus disease 2019 (COVID-19)
symptoms ≥28 days after clinical onset, is an emerging challenge to healthcare systems. …

[HTML][HTML] Impact of vitamin D deficiency on COVID-19—a prospective analysis from the CovILD Registry

A Pizzini, M Aichner, S Sahanic, A Böhm, A Egger… - Nutrients, 2020 - mdpi.com
The novel Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus type 2 (SARS-CoV-2) is a global health concern. Vitamin D (VITD) …

Neurological outcomes 1 year after COVID‐19 diagnosis: A prospective longitudinal cohort study

…, P Kindl, L Putnina, E Fava, S Sahanic… - European journal of …, 2022 - Wiley Online Library
Background and purpose Neurological sequelae from coronavirus disease 2019 (COVID‐19)
may persist after recovery from acute infection. Here, the aim was to describe the natural …